| Product Code: ETC12702606 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Nuclear Medicines Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Nuclear Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 India Nuclear Medicines Market - Industry Life Cycle |
3.4 India Nuclear Medicines Market - Porter's Five Forces |
3.5 India Nuclear Medicines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Nuclear Medicines Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.7 India Nuclear Medicines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Nuclear Medicines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 India Nuclear Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of cancer in India leading to increased demand for nuclear medicines. |
4.2.2 Technological advancements in nuclear medicine imaging techniques. |
4.2.3 Rising investments in healthcare infrastructure and facilities in India. |
4.3 Market Restraints |
4.3.1 High cost associated with nuclear medicines and imaging procedures. |
4.3.2 Limited awareness and education among healthcare professionals and patients about the benefits of nuclear medicines. |
4.3.3 Stringent regulatory requirements and approval processes for nuclear medicines in India. |
5 India Nuclear Medicines Market Trends |
6 India Nuclear Medicines Market, By Types |
6.1 India Nuclear Medicines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Nuclear Medicines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Nuclear Medicines Market Revenues & Volume, By Diagnostic Radiopharmaceuticals, 2021 - 2031F |
6.1.4 India Nuclear Medicines Market Revenues & Volume, By Therapeutic Radiopharmaceuticals, 2021 - 2031F |
6.2 India Nuclear Medicines Market, By Application Area |
6.2.1 Overview and Analysis |
6.2.2 India Nuclear Medicines Market Revenues & Volume, By Oncology Imaging, 2021 - 2031F |
6.2.3 India Nuclear Medicines Market Revenues & Volume, By Thyroid Treatment, 2021 - 2031F |
6.2.4 India Nuclear Medicines Market Revenues & Volume, By Cardiac Imaging, 2021 - 2031F |
6.2.5 India Nuclear Medicines Market Revenues & Volume, By Bone Pain Palliation, 2021 - 2031F |
6.3 India Nuclear Medicines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Nuclear Medicines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 India Nuclear Medicines Market Revenues & Volume, By Endocrinology Clinics, 2021 - 2031F |
6.3.4 India Nuclear Medicines Market Revenues & Volume, By Cardiology Centers, 2021 - 2031F |
6.3.5 India Nuclear Medicines Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.4 India Nuclear Medicines Market, By Product Type |
6.4.1 Overview and Analysis |
6.4.2 India Nuclear Medicines Market Revenues & Volume, By Technetium-99m, 2021 - 2031F |
6.4.3 India Nuclear Medicines Market Revenues & Volume, By Iodine-131, 2021 - 2031F |
6.4.4 India Nuclear Medicines Market Revenues & Volume, By Thallium-201, 2021 - 2031F |
6.4.5 India Nuclear Medicines Market Revenues & Volume, By Samarium-153, 2021 - 2031F |
7 India Nuclear Medicines Market Import-Export Trade Statistics |
7.1 India Nuclear Medicines Market Export to Major Countries |
7.2 India Nuclear Medicines Market Imports from Major Countries |
8 India Nuclear Medicines Market Key Performance Indicators |
8.1 Number of nuclear medicine imaging procedures conducted annually. |
8.2 Adoption rate of new nuclear medicine technologies in Indian healthcare facilities. |
8.3 Investment trends in research and development of nuclear medicines in India. |
9 India Nuclear Medicines Market - Opportunity Assessment |
9.1 India Nuclear Medicines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Nuclear Medicines Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.3 India Nuclear Medicines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Nuclear Medicines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 India Nuclear Medicines Market - Competitive Landscape |
10.1 India Nuclear Medicines Market Revenue Share, By Companies, 2024 |
10.2 India Nuclear Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here